Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 42, Issue 2, 1998, Pages 269-278

  Saito, Isamu ^a   Asano, Takao ^b   Sano, Keiji ^c   Takakura, Kintomo ^d   Abe, Hiroshi ^e   Yoshimoto, Takashi ^f   Kikuchi, Haruhiko ^g   Ohta, Tomio ^h   Ishibashi, Sadahiko ⁱ  

^a KYORIN UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Fuji Brain Institute and Hospital   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^h OSAKA MEDICAL COLLEGE   (Japan)

ⁱ HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Clinical trial; Neuroprotective agent; Subarachnoid hemorrhage

Indexed keywords

EBSELEN;

ADULT; AGED; ANEURYSM RUPTURE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN PROTECTION; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE;

AGED; ANTIOXIDANTS; AZOLES; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; ORGANOSELENIUM COMPOUNDS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031886421     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199802000-00038     Document Type: Article

References (38)

1. Asano T, Sasaki T, Koide T, Takakura K, Sano K: Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res 6:49-53, 1984.
2. Cotgreave IA, Duddy SK, Kass GE, Thompson D, Moldéus P: Studies on the anti-inflammatory activity of ebselen: Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C? Biochem Pharmacol 38: 649-656, 1989.
3. Cotgreave IA, Johansson U, Westergren G, Moldéus PW, Brattsand R: The anti-inflammatory activity of ebselen but not thiols in experimental alveolitis and bronchiolitis. Agents Actions 24:313-319, 1988.
4. Dawson DA, Masayasu H, Graham DI, Macrae IM: The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci Lett 185:65-69, 1995.
5. Drake CG: Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 68:985-986, 1988.
6. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
7. Hall ED, Braughler JM: Central nervous system trauma and stroke: II - Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med 6:303-313, 1989.
8. Hall ED, Andrus PK, Althaus JS, VonVoigtlander PF: Hydroxyl radical production and lipid peroxidation parallels selective post-ischemic vulnerability in gerbil brain. J Neurosci Res 34:107-112, 1993.
9. Hattori R, Inoue R, Sase K, Eizawa H, Kosuga K, Aoyama T, Masayasu H, Kawai C, Sasayama S, Yui Y: Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur J Pharmacol 267:R1-R2, 1994.
10. Hayashi M, Slater TF: Inhibitory effects of ebselen on lipid peroxidation in rat liver microsomes. Free Radic Res Commun 2:179-185, 1986.
11. Hunt WE, Kosnik EJ: Timing and perioperative care in intracranial aneurysm surgery. Clin Neurosurg 21:79-89, 1974.
12. Ichikawa S, Omura K, Katayama T, Okamura N, Ohtsuka T, Ishibashi S, Masayasu H: Inhibition of superoxide anion production in guinea pig polymorphonuclear leukocytes by a seleno-organic compound, ebselen. J Pharmacobiodyn 10:595-597, 1987.
13. Johshita H, Sasaki T, Matsui T, Hanamura T, Masayasu H, Asano T, Takakura K: Effects of ebselen (PZ51) on ischaemic brain oedema after focal ischaemia in cats. Acta Neurochir 51:239-241, 1990.
14. Kanamaru K, Weir BK, Simpson I, Witbeck T, Grace M: Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 74:454-459, 1991.
15. Klonoff PS, Snow WG, Costa LD: Quality of life in patients 2 to 4 years after closed head injury. Neurosurgery 19:735-743, 1986.
16. 4 in human and porcine leukocytes by isomerisation to its 5s,12R-6-trans-isomer. Prostaglandins 31: 1029-1048, 1986.
17. Maiorino M, Roveri A, Coassin M, Ursini F: Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol 37:2267-2271, 1988.
18. Masumoto H, Sies H: The reaction of ebselen with peroxynitrite. Chem Res Toxicol 9:262-267, 1996.
19. Matsui T, Johshita H, Asano T, Tanaka J: Effect of a free radical scavenger, ebselen, on cerebral ischemia, in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenschaftliche Verlagsgesellschaft mbH., 1990, pp 363-367.
20. Müller A, Cadenas E, Graf P, Sies H: A novel biologically active seleno-organic compound: I - Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem Pharmacol 33:3235-3239, 1984.
21. Müller A, Gabriel H, Sies H: A novel biologically active selenoorganic compound: IV - Protective glutathione-dependent effect of PZ 51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes. Biochem Pharmacol 34:1185-1189, 1985.
22. Nozawa R, Arai M, Kuruto R, Motohashi T, Masayasu H: Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. J Pharm Pharmacol 48:64-67, 1996.
23. Ohta T, Kikuchi H, Hashi K, Kudo Y: Nizofenone administration in the acute stage following subarachnoid hemorrhage. J Neurosurg 64:420-426, 1986.
24. Parnham MJ, Graf E: Commentary: Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol 36:3095-3102, 1987.
25. Safayhi H, Tiegs G, Wendel A: A novel biologically active seleno-organic compound: V - Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol 34:2691-2694, 1985.
26. Saito I, Asano T, Ochiai C, Takakura K, Tamura A, Sano K: A double-blind clinical evaluation of the effect of nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture. Neurol Res 5:29-47, 1983.
27. Sakaki S, Ohta S, Nakamura H, Takeda S: Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 8:1-8, 1988.
28. Siesjo BK: Pathophysiology and treatment of focal cerebral ischemia: Part II - Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992.
29. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K: Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: A randomized double-blind study. Neurol Res 11:79-88, 1989.
30. Tanaka J, Yamada F: Ebselen (PZ51) inhibits the formation of ischemic brain edema, in Wendel A (ed): Selenium in Biology and Medicine. Berlin, Springer-Verlag, 1989, pp 173-176.
31. Teasdale G, Jennett B: Assessment of coma and impaired consciousness: A practical scale. Lancet 2:81-84, 1974.
32. Ueda S, Yoshikawa T, Oyamada H, Takemura T, Morita Y, Yoshida N, Sugino S, Kondo M, Kurebayashi Y, Ikeda T: Effects of ebselen on acute gastric mucosal injury in rats, in Hayaishi O, Niki E, Kondo M, Yoshikawa T (eds): Medical, Biochemical and Chemical Aspects of Free Radicals. Amsterdam, Elsevier Science Publishers, 1989, pp 535-538.
33. Ullrich V, Weber P, Meisch F, Appen F: Ebselen-binding equilibria between plasma and target proteins. Biochem Pharmacol 52:15-19, 1996.
34. Wagner G, Schuch G, Akerboom TPM, Sies H: Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem Pharmacol 48:1137-1144, 1994.
35. Watanabe T, Asano T, Shimizu T, Seyama Y, Takakura K: Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 50:1145-1150, 1988.
36. Watanabe T, Nishiyama M, Okamoto H, Hori T, Asano T, Shimizu T, Masayasu H: Effects of ebselen (PZ51) on experimental cerebral vasospasm, in Wendel A (ed): Selenium in Biology and Medicine. Berlin, Springer-Verlag, 1989, pp 177-184.
37. Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R: A novel biologically active seleno-organic compound: II - Activity of PZ51 in relation to glutathione peroxidase. Biochem Pharmacol 33:3241-3245, 1984.
38. Zini I, Tomasi A, Grimaldi R, Vannini V, Agnati LF: Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis. Neurosci Lett 138:279-282, 1992.